GEN vs HAE · P/E 17, rev $5.00B vs P/E 35, rev $1.36B
Gen Digital Inc. (GEN) versus Haemonetics Corporation (HAE) — a side-by-side from cached financials, not a winner call.
Gen Digital Inc. (GEN) is a software - infrastructure company listed on US.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Latest reported GEN revenue for 2026-04-03 was $5.00B. Net income was $973.0M. Revenue was up 27.1% from 2025-03-28 to 2026-04-03. GEN currently screens at market cap $15.83B and trailing P/E 16.7.
Latest reported HAE revenue for 2025-03-29 was $1.36B. Net income was $167.7M. Revenue was up 4.0% from 2024-03-30 to 2025-03-29. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
GEN currently screens at market cap $15.83B and trailing P/E 16.7. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Not investment advice. Open the GEN and HAE stock pages for the full models.
Not investment advice.